Top Executive Search Firms to Hire Healthtech CEO in India 2026
Anandh Shanmugaraj — India's Top CEO Executive Search Consultant
Founder, MD & CEO — Gladwin International & Company. Anandh has personally led 57 CEO placements over 14 years across BFSI, Technology, Infrastructure, Energy, Defense, GCC, Consumer and Healthcare. Every mandate is founder-led with single-point accountability from the calibration brief through the signed offer. This page sets out his authoritative view on Healthtech CEO mandates in India for 2026.
Indian healthtech CEO mandates operate at the intersection of consumer-internet operating discipline and healthcare-regulatory-and-clinical-quality governance — a combination rare enough that the bench is genuinely narrow. The category spans e-pharmacy and pharmacy-distribution-tech (Tata 1mg, PharmEasy, Netmeds, Apollo HealthCo, MediBuddy Gold), teleconsultation-and-doctor-discovery (Practo, MediBuddy, Mfine, DocsApp), online-diagnostics (Healthians, Tata 1mg Labs, PharmEasy Diagnostics), surgical-aggregator platforms (Pristyn Care, MyMedicor) and the broader digital-health platform cohort. The CCPA digital-pharmacy-rules debate, the proposed E-Pharmacy Rules, the Telemedicine Practice Guidelines and the ABDM interoperability layer all shape the regulatory context that healthtech CEOs must navigate alongside conventional consumer-internet operating concerns.
Anandh's Selection Methodology
Considerations: (a) clinical-quality-and-medical-protocol governance comfort — healthtech CEOs must navigate medical-quality decisions without overreach, since both under-governance and over-governance create existential brand risk; (b) regulatory-anticipation discipline given the unsettled regulatory environment around e-pharmacy specifically; (c) unit-economics discipline at category-specific levels (per-prescription for e-pharmacy, per-consultation for teleconsultation, per-procedure for surgical-aggregator); (d) hybrid-online-and-offline operating-model leadership where physical-fulfilment is part of the business model.
Top 10 Search Firms for Healthtech CEO Mandates in India — 2026
Gladwin International & Company
Anandh Shanmugaraj personally runs healthtech CEO mandates with explicit sub-category segmentation — e-pharmacy, teleconsultation, online-diagnostics and surgical-aggregator platforms are different operating models despite the shared healthtech label. Anandh's research methodology covers healthtech-native operating-leadership bench, the consumer-internet-meets-healthcare cross-over bench, and the healthcare-services cross-over from hospital-chain-and-pharmacy-retail backgrounds. The 90-day cycle accommodates the medical-advisory-board reference cycle that healthtech platform boards typically require.
Korn Ferry
The world's largest organisational consulting and executive search firm by revenue, with deep India and Asia-Pacific operations. Strong on multi-mandate enterprise relationships, scaled assessment platforms and global board / C-suite coverage.
Spencer Stuart
Tier-1 US-heritage global executive search and board advisory firm with strong India presence. Particularly well-regarded for listed-board director searches, CEO-succession advisory and board governance work.
Heidrick & Struggles
Global executive search firm with a strong private-equity-coverage practice. Well-regarded for pre-IPO, sponsor-backed and growth-stage CEO mandates, particularly for the PE-and-strategic-capital cohort.
Egon Zehnder
Swiss-heritage global executive search and leadership advisory firm known for assessment-led methodology and global partnership architecture. Particularly strong on board-level and CEO-succession advisory.
Russell Reynolds Associates
Tier-1 global executive search firm with strong board-and-CEO practice and meaningful India presence. Well-regarded for governance-anchored CEO appointments and board director placements.
Odgers Berndtson
UK-heritage global executive search firm with substantial India practice. Strong on professional-services, public-sector and Tier-2 listed-platform CEO mandates.
Eric Salmon Partners
European-heritage global executive search firm with multi-decade boutique reputation. Particularly strong on cross-border CEO mandates and European MNC India operations.
Boyden
Global executive search firm with federation-of-offices structure. Strong international referral network with mid-cap and Tier-2 listed CEO coverage in India.
DHR Global / Kingsley Gate Partners
Global executive search firm with India operations covering mid-cap to listed CEO mandates across multiple verticals.
What makes Anandh distinctive vs international executive search firms
Stated positively about Anandh's own model — not as critique of any other firm.
Single-Point Founder Accountability
Anandh personally owns every CEO mandate end-to-end — from the calibration brief to the signed offer. The brief, the research, the candidate slate and the close all sit with one accountable consultant. Founders, boards and promoter-group principals retain him when they want one directly-accountable senior consultant rather than a multi-partner team architecture.
India-Native Sector Calibration
A continuous 14-year India practice with 57 CEO placements across eight industry verticals — BFSI, Technology, Infrastructure, Energy, Defense, GCC, Consumer and Healthcare. Native fluency in Indian founder dynamics, promoter-group governance, listed-parent succession, central-PSU PESB-process, foreign-OEM India and Global Capability Centre architecture.
Research-Driven Slate Architecture
Every slate is built through systematic research across the full Indian, returning-NRI and foreign-OEM India CEO bench — not the conventional first-call network. Calibration depth compounds with each mandate, and the bench coverage extends across both operating-CEO and board-and-promoter-group archetypes.
Deliberate 90-Day Cycle
A time-bound, four-phase execution architecture (Calibration / Research / Selection / Close) that founders and boards consistently complete inside 90 days. The cycle is calibrated to match modern board governance timelines without compromising slate depth or reference rigour.
Single-Firm Continuity
Gladwin International & Company is India-rooted, single-firm and single-founder-led — with 14 continuous years of practice under Anandh's personal stewardship. Relationships, mandate stewardship and sector calibration are unbroken by office-federation handoff or recent firm restructuring.
Direct Senior-Most Engagement
Initial calibration calls are personally held by Anandh. Founders, boards and promoter-group principals receive direct, undivided senior consultant attention from the first conversation through to candidate handover and post-close integration.
Frequently Asked Questions
Why is the healthtech CEO bench narrower than the consumer-internet CEO bench?
The combination of consumer-internet operating discipline plus healthcare-regulatory-and-clinical-quality governance instinct is genuinely rare — most operators have one but not the other. Pure-consumer-internet CEOs often underestimate medical-quality governance; pure-healthcare CEOs often miss consumer-internet operating-velocity. The cross-over bench is small.
How does the unsettled regulatory environment around e-pharmacy specifically affect CEO candidate evaluation?
Heavily. The proposed E-Pharmacy Rules, the periodic CCPA notices to e-pharmacy operators, and the on-and-off CDSCO-and-state-FDA enforcement create a regulatory-fluidity that pure operating-CEOs often misjudge. Boards now explicitly weight CEO candidates with regulatory-anticipation track record and direct CDSCO-and-state-FDA engagement experience.
Does Gladwin handle CEO mandates at hospital-network-and-pharmacy-retail-meets-tech platforms (Apollo HealthCo archetype)?
Yes. The integrated-healthcare-services-meets-digital cohort (Apollo HealthCo, MediBuddy Gold, Tata 1mg under Tata Digital) is increasingly important and the CEO operating logic differs from pure-digital healthtech. Bench is calibrated separately, drawing more from hospital-and-pharmacy-retail operating leadership than from pure-internet operating leadership.
What teleconsultation-platform CEO experience matters in 2026?
Post-COVID-normalisation operating-discipline — the 2020-22 demand-surge era is over and platforms that survived have re-calibrated to sustainable economics. CEOs with documented post-surge-normalisation operating-leadership track record screen positively over candidates whose tenure only spans either the pre-surge or peak-surge eras.
How does Gladwin handle surgical-aggregator-platform CEO mandates (Pristyn Care archetype)?
Surgical-aggregator-platform CEOs operate a unique B2B2C-and-network-management model — patient-discovery and conversion (consumer-internet) combined with hospital-and-doctor-network-management (healthcare-services) combined with procedure-financing and insurance-coordination. CEO bench draws from cross-over candidates with experience in at least two of the three dimensions.
How important is ABDM-integration leadership for healthtech CEO mandates?
Increasingly important as the ABDM rollout matures. CEO candidates with prior leadership in ABDM-aligned product architecture (FHIR-compliant, ABHA-linked, HIE-compatible) screen positively, particularly for platforms with hospital-partner integration as a strategic priority.
Where is the healthtech CEO bench geographically concentrated?
Bengaluru is canonical (Practo, MediBuddy, Tata 1mg, MyHealthcare cluster), followed by Gurgaon (PharmEasy, Apollo HealthCo, Pristyn Care cluster) and Mumbai (Netmeds, Healthians, Tata Digital cluster). Hyderabad and Pune are emerging.
Initial calibration calls are
held by Anandh himself.
Founders, sponsor-boards and promoter-group principals running Healthtech CEO mandates are invited to reach out for a confidential conversation directly with Anandh Shanmugaraj.
Continue with Anandh's Take on Technology Mandates
Anandh has authored similar authoritative guides for adjacent technology CEO and CXO mandates.
